Raychaudhuri S. MicroRNAs overexpressed in growth-restricted rat skeletal muscles regulate the glucose transport in cell culture targeting central TGF-beta factor SMAD4. PLoS One 2012;7:e34596.CrossrefWeb of SciencePubMedGoogle Scholar
Schlein C, Talukdar S, Heine M, Fischer AW, Krott LM, et al. FGF21 Lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues. Cell Metab 2016;23:441–53.Web of ScienceCrossrefGoogle Scholar
Fisher FM, Chui PC, Nasser IA, Popov Y, Cunniff JC, et al. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology 2014;147:1073–83.e1076.PubMedCrossrefWeb of ScienceGoogle Scholar
Kim SH, Kim KH, Kim HK, Kim MJ, Back SH, et al. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia 2015;58:809–18.CrossrefWeb of SciencePubMedGoogle Scholar
Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010;59:2781–9.CrossrefPubMedWeb of ScienceGoogle Scholar
Ko BJ, Kim SM, Park KH, Park HS, Mantzoros CS. Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children. Int J Obes (Lond) 2014;38:1497–502.PubMedCrossrefGoogle Scholar
Reinehr T, Woelfle J, Wunsch R, Roth CL. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metab 2012;97:2143–50.CrossrefWeb of SciencePubMedGoogle Scholar
Giannini C, Feldstein AE, Santoro N, Kim G, Kursawe R, et al. Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. J Clin Endocrinol Metab 2013;98:2993–3000.CrossrefPubMedWeb of ScienceGoogle Scholar
Mikolajczak A, Oswiecimska JM, Swietochowska E, Roczniak W, Ziora KT. Serum FGF21 in girls with anorexia nervosa – comparison to normal weight and obese female adolescents. Neuro Endocrinol Lett 2017;38:173–81.PubMedGoogle Scholar
Li G, Yin J, Fu J, Li L, Grant SF, et al. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: the BCAMS study. Diabetes Metab 2017;43:253–60.Web of SciencePubMedCrossrefGoogle Scholar
Bisgaard A, Sorensen K, Johannsen TH, Helge JW, Andersson AM, et al. Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents. Int J Pediatr Endocrinol 2014;2014:7.CrossrefPubMedGoogle Scholar
Hanks LJ, Casazza K, Ashraf AP, Wallace S, Gutierrez OM. Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females. Clin Endocrinol (Oxf) 2015;82:550–6.CrossrefPubMedGoogle Scholar
Zhang M, Zeng L, Wang YJ, An ZM, Ying BW. Associations of fibroblast growth factor 21 gene 3′ untranslated region single-nucleotide polymorphisms with metabolic syndrome, obesity, and diabetes in a Han Chinese population. DNA Cell Biol 2012;31:547–52.Web of ScienceCrossrefGoogle Scholar
Tanaka T, Ngwa JS, van Rooij FJ, Zillikens MC, Wojczynski MK, et al. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am J Clin Nutr 2013;97:1395–402.CrossrefWeb of SciencePubMedGoogle Scholar
Chu AY, Workalemahu T, Paynter NP, Rose LM, Giulianini F, et al. Novel locus including FGF21 is associated with dietary macronutrient intake. Hum Mol Genet 2013;22:1895–902.Web of ScienceCrossrefPubMedGoogle Scholar
Soberg S, Sandholt CH, Jespersen NZ, Toft U, Madsen AL, et al.FGF21 is a sugar-induced hormone associated with sweet intake and preference in humans. Cell Metab 2017;25:1045–53.e1046.Web of SciencePubMedCrossrefGoogle Scholar
Frayling TM, Beaumont RN, Jones SE, Yaghootkar H, Tuke MA, et al. A common allele in FGF21 associated with sugar intake is associated with body shape, lower total body-fat percentage, and higher blood pressure. Cell Rep 2018;23:327–36.PubMedWeb of ScienceCrossrefGoogle Scholar
WHO AnthroPlus for personal computers Manual: software for assessing growth of the world’s children and adolescents. Geneva 2009. Available at: http://www.who.int/growthref/tools/en/.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.CrossrefPubMedGoogle Scholar
Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010;139:456–63.CrossrefPubMedWeb of ScienceGoogle Scholar
Crujeiras AB, Gomez-Arbelaez D, Zulet MA, Carreira MC, Sajoux I, et al. Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress? Int J Obes (Lond) 2017;41:1570–8.PubMedCrossrefGoogle Scholar
Iglesias P, Selgas R, Romero S, Diez JJ. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. Eur J Endocrinol 2012;167:301–9.PubMedWeb of ScienceCrossrefGoogle Scholar
About the article
Published Online: 2019-07-16
Published in Print: 2019-09-25
Author contributions: A.J.R.P. and G.M.H. contributed to data collection, experimental execution, literature search and generation of figures and tables; Y.R.N. and M.L.L.d.l.V.M. wrote the manuscript and performed the statistical analysis; A.J.A.C. and M.d.C.P.P. contributed to data interpretation and performed the statistical analysis; R.R.S. contributed to experimental analysis and data acquisition; L.d.R.I.R. contributed to the study design, wrote the manuscript and reviewed/edited the manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This study was supported by a grant from the Secretary of Public Education of Mexico (PRODEP-SEP UGTO-PTC-439).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: None declared.